Arizona State Retirement System Takes $121,000 Position in Aspen Aerogels, Inc. (NYSE:ASPN)

Arizona State Retirement System bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,270 shares of the construction company’s stock, valued at approximately $121,000.

A number of other hedge funds also recently added to or reduced their stakes in ASPN. Koch Industries Inc. purchased a new position in Aspen Aerogels in the 1st quarter worth approximately $61,788,000. Point72 Asset Management L.P. raised its stake in Aspen Aerogels by 442.6% during the 3rd quarter. Point72 Asset Management L.P. now owns 579,739 shares of the construction company’s stock valued at $5,345,000 after buying an additional 472,889 shares during the last quarter. Vanguard Group Inc. raised its stake in Aspen Aerogels by 29.1% during the 3rd quarter. Vanguard Group Inc. now owns 1,860,576 shares of the construction company’s stock valued at $17,154,000 after buying an additional 419,657 shares during the last quarter. New York State Common Retirement Fund raised its stake in Aspen Aerogels by 1,844.7% during the 4th quarter. New York State Common Retirement Fund now owns 383,696 shares of the construction company’s stock valued at $4,524,000 after buying an additional 363,966 shares during the last quarter. Finally, Cowen Prime Advisors LLC raised its stake in Aspen Aerogels by 43.8% during the 4th quarter. Cowen Prime Advisors LLC now owns 1,051,925 shares of the construction company’s stock valued at $12,402,000 after buying an additional 320,575 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Benchmark raised shares of Aspen Aerogels from a “hold” rating to a “buy” rating and set a $14.00 price objective for the company in a research report on Monday, March 20th. HC Wainwright reaffirmed a “buy” rating on shares of Aspen Aerogels in a report on Friday, May 5th. B. Riley reaffirmed a “buy” rating on shares of Aspen Aerogels in a report on Friday, April 28th. Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $20.00 to $18.00 and set a “buy” rating for the company in a report on Friday, February 17th. Finally, StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Saturday, May 13th. One investment analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $24.13.

Aspen Aerogels Trading Down 3.6 %

Shares of NYSE:ASPN opened at $6.49 on Friday. Aspen Aerogels, Inc. has a 52 week low of $5.41 and a 52 week high of $21.48. The company’s 50 day moving average is $6.82 and its two-hundred day moving average is $9.70. The company has a current ratio of 4.30, a quick ratio of 3.91 and a debt-to-equity ratio of 0.25. The company has a market cap of $455.01 million, a PE ratio of -3.47 and a beta of 2.10.

Aspen Aerogels Profile

(Get Rating)

Aspen Aerogels, Inc engages in designing, developing, and manufacturing aerogel insulation used primarily in the energy infrastructure and building materials markets. Its products include Cryogel, Pyrogel, and Spaceloft. The company was founded by Hamed S. Borhanian, Patrick J. Piper, and Kang P. Lee in May 2001 and is headquartered in Northborough, MA.